159 related articles for article (PubMed ID: 10809995)
1. Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety.
Gavish D; Leibovitz E; Shapira I; Rubinstein A
J Intern Med; 2000 May; 247(5):563-9. PubMed ID: 10809995
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
3. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
Goa KL; Barradell LB; Plosker GL
Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
Jeck T; Riesen WF; Keller U
Diabet Med; 1997 Jul; 14(7):564-70. PubMed ID: 9223394
[TBL] [Abstract][Full Text] [Related]
5. Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus.
de Vries R; Dikkeschei BD; Sluiter WJ; Dallinga-Thie GM; van Tol A; Dullaart RP
Clin Lab; 2012; 58(11-12):1231-9. PubMed ID: 23289194
[TBL] [Abstract][Full Text] [Related]
6. Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy.
Ohmichi M; Ikegami H; Kurachi H; Node K; Morishige K; Nishio Y; Adachi K; Matumoto K; Hayakawa J; Tasaka K; Azuma C; Murata Y
Maturitas; 2001 May; 38(3):279-86. PubMed ID: 11358645
[TBL] [Abstract][Full Text] [Related]
7. Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.
Hutchesson AC; Moran A; Jones AF
J Clin Pharm Ther; 1994 Dec; 19(6):387-9. PubMed ID: 7876371
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes.
Triolo M; Annema W; de Boer JF; Tietge UJ; Dullaart RP
Eur J Clin Invest; 2014; 44(3):240-8. PubMed ID: 24325778
[TBL] [Abstract][Full Text] [Related]
9. The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.
Stewart MW; Dyer RG; Alberti KG; Laker MF
Diabet Med; 1995 Mar; 12(3):250-7. PubMed ID: 7758262
[TBL] [Abstract][Full Text] [Related]
10. Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
Papadakis JA; Ganotakis ES; Jagroop IA; Winder AF; Mikhailidis DP
Int J Cardiol; 1999 Jun; 69(3):237-44. PubMed ID: 10402106
[TBL] [Abstract][Full Text] [Related]
11. Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.
Kappelle PJ; Ahnström J; Dikkeschei BD; de Vries R; Sluiter WJ; Wolffenbuttel BH; van Tol A; Nielsen LB; Dahlbäck B; Dullaart RP
Atherosclerosis; 2010 Nov; 213(1):247-50. PubMed ID: 20828695
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Didangelos TP; Carina MV; Kranitsas DF; Kontopoulos AG
Am J Cardiol; 1997 Sep; 80(5):608-13. PubMed ID: 9294990
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels.
Spieker LE; Noll G; Hannak M; Lüscher TF
J Cardiovasc Pharmacol; 2000 Mar; 35(3):361-5. PubMed ID: 10710119
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
Bruckert E; De Gennes JL; Malbecq W; Baigts F
Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
[TBL] [Abstract][Full Text] [Related]
18. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil).
Farnier M; Salko T; Isaacsohn JL; Troendle AJ; Dejager S; Gonasun L
Am J Cardiol; 2003 Oct; 92(7):794-7. PubMed ID: 14516878
[TBL] [Abstract][Full Text] [Related]
19. The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.
Muhlestein JB; May HT; Jensen JR; Horne BD; Lanman RB; Lavasani F; Wolfert RL; Pearson RR; Yannicelli HD; Anderson JL
J Am Coll Cardiol; 2006 Jul; 48(2):396-401. PubMed ID: 16843192
[TBL] [Abstract][Full Text] [Related]
20. Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.
Keating GM; Ormrod D
Drugs; 2002; 62(13):1909-44. PubMed ID: 12215067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
